ALLMedicine™ Thrombophlebitis Center

Mar 22nd, 2023 - Practice Essentials Superficial thrombophlebitis is a common inflammatory-thrombotic disorder in which a thrombus develops in a vein located near the surface of the skin. Most superficial veins that develop thrombosis also have phlebitis, in contr...

Mar 19th, 2023 - Anticoagulant-related nephropathy (ARN) is a rare, newly recognized cause of acute kidney injury and significant but underdiagnosed complication of anticoagulation therapy. ARN occurs in patients taking oral anticoagulant therapy most often warfar...

Mar 16th, 2023 - When head and neck infection is suspected, appropriate imaging contributes to treatment decisions and prognosis. While contrast-enhanced CT is the standard imaging modality for evaluating head and neck infections, MRI can better characterize the s...

Mar 14th, 2023 - Thrombophlebitis is a known complication of head and neck infection, which can result in propagation of infected thrombi and associated complications. While antegrade/downstream propagation of thrombus is well described-the Lemierre syndrome-throm...

Mar 10th, 2023 - The most common mass in the popliteal fossa, Baker cyst, also termed popliteal cyst, results from fluid distention of the gastrocnemio-semimembranosus bursa, which is located in the medial aspect of the popliteal fossa.[1] The eponym honors the wo...

Aug 31st, 2016 - Postpartum infections remain a leading cause of neonatal morbidity and mortality worldwide. A high percentage of these infections may stem from bacterial colonization of the umbilicus, because cord care practices vary in reflection of cultural tra...

Mar 9th, 2023 - INCB7839 is an inhibitor of the ADAM (A Disintegrin and Metalloprotease) 10 and 17 proteases. Neuronal activity regulates glioma growth through neuroligin-3 (NLGN3). ADAM 10 is the protease responsible for NLGN3 release into the tumor microenviron...

Feb 24th, 2023 - Central venous catheters improve the tolerability and feasibility of patient care in the hospital setting by allowing the administration of hyper-osmotic, vesicant and venotoxic fluids. Despite these advantages, the long-term presence of central v...

Feb 13th, 2023 - INTRODUCTION AND RATIONALE Since its introduction, central venous catheter (CVC) use has been increasing and is now indispensable in modern-day medical practice. Besides its imperative use in critically ill patients, there are multiple complicatio...

Jan 26th, 2023 - Retronychia is the growth of the proximal nail plate into the proximal nail fold which was first described in 1999 by De Berker and Rendall. The disorder is common and most frequently affects women (~82%); the estimated average age is 39 years. Th...

Jan 6th, 2023 - Current traditional prosthetic chest harnessing worn by women Veterans with limb loss) is less than optimal due to female anatomy. The investigators know from the sports and seat belt/airbag literature that breast tissue injuries can disrupt the b...

Oct 6th, 2021 - Rachel Regn, MD Ob/Gyn Resident, Postgraduate Year 2 William-Robinson, MD Maxwell E Lapham Professor of Gynecologic Oncology Tulane Cancer Center Tulane University School of Medicine The goal of palliative care (PC) is to ...

Oct 6th, 2021 - A new study has provided yet more evidence that survivors of endometrial cancer should be closely monitored for cardiovascular disease. These women are at higher risk for various long-term cardiovascular problems compared with their cancer-free co...

May 13th, 2021 - Ralph Boccia, MD: The most common adverse events that were seen with trilaciclib were fatigue, hypocalcemia, and hypokalemia. If you look at the 2 arms of the study, numerically each was in the 25% range, compared with roughly the 20% range. There...

Jan 18th, 2021 - The phase 2 TAMARIN study exploring the activity of tamoxifen on driver variant allele frequency (VAF) in patients with stable myeloproliferative neoplasms (MPN) met its primary end point, said Simón Méndez-Ferrer, PhD, who presented the data duri...

Dec 4th, 2020 - The FDA approved single-dose fosaprepitant dimeglumine (Emend for injection) in combination with other antiemetic agents for the prevention of delayed chemotherapy-induced nausea and vomiting (CINV) following moderately emetogenic chemotherapy (ME...